1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Clinical data commonly used as prognostic factors for the 25 patients with ALS

Clinical DataPatients with ALS
Baseline1-Year Follow-Up Subgroup
Body mass index at MRI (± SD)23.7 ± 2.724.0 ± 2.7
Familial transmission2 SOD1 mutated1 SOD1 mutated
Site of onset1 bulbar; 18 upper; 6 lower1 bulbar; 12 upper; 6 lower
Delay from first symptom to diagnosis, mo ± SD9.9 ± 5.610.7 ± 6.0
  • Note:SOD1 indicates SuperOxide Dismutase 1 gene.